CDZIP vs REGN · rev $16.3M vs P/E 14, rev $14.34B
Cadiz Inc. Depositary Shares (CDZIP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Cadiz Inc. Depositary Shares (CDZIP) is a utilities - regulated water company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CDZIP revenue for 2025-12-31 was $16.3M. Net income was -$34.2M. Revenue was up 69.8% from 2024-12-31 to 2025-12-31. CDZIP currently screens at market cap $0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CDZIP currently screens at market cap $0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CDZIP and REGN stock pages for the full models.
Not investment advice.